Urinary D-serine level as a predictive biomarker for deterioration of renal function in patients with atherosclerotic risk factors.
Iwakawa, Hidehiro; Makabe, Shin; Ito, Tomokazu; Yoshimura, Tohru; Watanabe, Hiroyuki.
; 24(2): 159-165, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30252501
Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial.
DNA damage products (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines as potential biomarkers in human urine for atherosclerosis.
Differential urinary proteins to diagnose coronary heart disease based on iTRAQ quantitative proteomics.
Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.
Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
Significance of urinary 11-dehydro-thromboxane B<sub>2</sub> in age-related diseases: Focus on atherothrombosis.
Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis.
Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry.
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness.
Plaque regression in one artery is not necessarily associated with parallel changes in other vascular beds.